InnovaDerma PLC Director/PDMR Shareholding (0504V)
November 28 2019 - 9:21AM
UK Regulatory
TIDMIDP
RNS Number : 0504V
InnovaDerma PLC
28 November 2019
LEI: 213800WRAP6W8VDL6B38
InnovaDerma PLC
("InnovaDerma" or the "Company")
Director/PDMR shareholding
InnovaDerma (LSE: IDP), a UK developer of life sciences, beauty
and personal care products, announces that it was notified today,
Joseph Bayer, Executive Chairman has purchased 11,001 Ordinary
Shares of EUR0.10 each in the Company at a price of 60.00 pence per
Ordinary Share which will be held via his Australian Superannuation
Fund which Mr Bayer controls. He now holds 126,000 via his
Australian Superannuation Fund.
Therefore, Joseph Bayer's total interest in the Company through
direct and indirect holdings is 158,840 Ordinary Shares
representing approximately 1.10% of the issued share capital of the
Company.
This announcement contains inside information for the purposes
of Article 7 of EU Regulation 596/2014.
Further enquiries
InnovaDerma
Haris Chaudhry/Joe Bayer +61 (0)3 9863 8030
finnCap Ltd
Geoff Nash/ Kate Bannatyne +44 (0)207 220 0500
Alice Lane/Manasa Patil - Corporate www.finncap.com
Broking
---------------------------
TB Cardew
Shan Shan Willenbrock/Tom Allison + 44 (0)20 7930 0777
Olivia Rosser innovaDerma@tbcardew.com
---------------------------
1. Details of the person discharging managerial responsibilities
/ person closely associated
a) Name Joseph Bayer
------------------------------- -----------------------------------
2. Reason for the Notification
--------------------------------------------------------------------
a) Position/status Executive Director
------------------------------- -----------------------------------
b) Initial notification/Amendment Initial notification
------------------------------- -----------------------------------
3. Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
--------------------------------------------------------------------
a) Name InnovaDerma PLC
------------------------------- -----------------------------------
b) LEI 213800WRAP6W8VDL6B38
------------------------------- -----------------------------------
4. Details of the transaction(s): section to be repeated
for (i) each type of instrument; (ii) each type of
transaction; (iii) each date; and (iv) each place where
transactions have been conducted
--------------------------------------------------------------------
a) Description of the EUR0.10 each ("Ordinary Shares")
Financial instrument,
type of instrument
Identification code IDP GB00BT9PTW34
------------------------------- -----------------------------------
b) Nature of the transaction Purchase of Ordinary Shares
------------------------------- -----------------------------------
c) Price(s) and volume(s) Volume and Price -11,001 Ordinary
Shares at 60 pence per share
------------------------------- -----------------------------------
d) Aggregated information:
Aggregated volume See 4c) above
Price
------------------------------- -----------------------------------
e) Date of the transaction 28 November 2019
------------------------------- -----------------------------------
f) Place of the transaction London Stock Exchange, Main Market
------------------------------- -----------------------------------
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
END
DSHUWUVRKRAAUAA
(END) Dow Jones Newswires
November 28, 2019 10:21 ET (15:21 GMT)
Innovaderma (LSE:IDP)
Historical Stock Chart
From Apr 2024 to May 2024
Innovaderma (LSE:IDP)
Historical Stock Chart
From May 2023 to May 2024
Real-Time news about Innovaderma Plc (London Stock Exchange): 0 recent articles
More Innovaderma Plc News Articles